PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-07-02

Date Title Company
02-Jul-2022 Seagen Announces Results from Pivotal MOUNTAINEER Trial Demonstrating Clinically Meaningful Antitumor Activity of TUKYSA® (tucatinib) in Combination with Trastuzumab in Previously Treated HER2-Positive Metastatic Colorectal Cancer Businesswire